Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions.


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
03 2019
Historique:
received: 27 03 2018
accepted: 20 07 2018
pubmed: 12 8 2018
medline: 28 10 2019
entrez: 12 8 2018
Statut: ppublish

Résumé

Thyroid nodules are a common finding, especially in iodine-deficient regions. Ultrasonographic scoring systems such as the Thyroid Imaging Reporting and Data System (TIRADS) are helpful in differentiating between benign and malignant thyroid nodules by offering a risk stratification model. Depending on the constellation or number of suspicious ultrasound features, a fine-needle biopsy is recommended. However, none of the previous TIRADS publications considered the functional status of the nodules. Hyperfunctioning thyroid nodules (HTNs) were presumed to exclude malignancy with a very high negative predictive value. Particularly in regions where the iodine supply is low, most HTNs are seen in patients with normal thyroid-stimulating hormone levels. Therefore, thyroid scintigraphy is essential for the detection of HTNs. We investigated whether TIRADS identifies HTNs as nonsuspicious.

Identifiants

pubmed: 30097501
pii: jnumed.118.211912
doi: 10.2967/jnumed.118.211912
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342-347

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Simone Schenke (S)

Institute of Nuclear Medicine Hanau, Giessen, Germany simoneschenke@web.de.

Philipp Seifert (P)

Clinic of Nuclear Medicine, Jena University Hospital, Jena, Germany.

Michael Zimny (M)

Institute of Nuclear Medicine Hanau, Giessen, Germany.

Thomas Winkens (T)

Clinic of Nuclear Medicine, Jena University Hospital, Jena, Germany.

Ina Binse (I)

Clinic of Nuclear Medicine, Essen University Hospital, Essen, Germany; and.

Rainer Görges (R)

Clinic of Nuclear Medicine, Essen University Hospital, Essen, Germany; and.
Group Practice for Nuclear Medicine Duisburg/Moers, Duisburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH